Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Alp, Keziban Merve (1) Birchmeier, Walter Prof. Dr. (7) Blankenstein, Thomas Prof. Dr. (2) Blüthgen, Nils (1) Dahlmann, Mathias Dr. (29) Daniel, Peter Prof. Dr. (3) Fritsche, Raphaela Dr. (2) Haas, Simon Dr. rer. nat. (1) Hartl, Kimberly (1) Herse, Florian PD Dr. (1) Holz, Maximilian (1) Horne, Arik (1) Hübner, Norbert Prof. Dr. (1) Ivics, Zoltan Dr. (2) Izsvak, Zsuzsanna Dr. (2) Janke, Jürgen Dr. (1) Janz, Martin Dr. (1) Kobelt, Dennis Dr. (51) Koch, Gudrun (1) Leutz, Achim Prof. Dr. (2) Malchin, Victoria (1) Mertins, Philipp Dr. (4) Na, Il-Kang Dr. (1) Nazare, Marc (1) Nguyen, Tam Hoai Dr. (1) Nimptsch, Katharina Dr. (1) Özerdem, Ceren (1) Pezzutto, Antonio Prof. Dr. (4) Pischon, Tobias Prof. Dr. (1) Popp, Oliver Dr. (3) Rathjen, Fritz Prof. Dr. (1) Rehm, Armin Dr. (1) Röefzaad, Claudia (1) Schlag, Peter M. Prof. Dr. (378) Schmitt, Clemens Prof. Dr. (2) Schöpe, Paul Curtis (2) Schroeder, Leif Dr. (1) Simon, Mareike Dr. (1) Solé Boldo, Llorenc Dr. rer. nat. (1) Specker, Edgar Dr. (2) Sperling, Silke Prof. Dr. (1) Sporbert, Anje Dr. (1) Stein, Ulrike Prof. Dr. (187) Torke, Sebastian Dr. (4) Uckert, Wolfgang Prof. Dr. (1) Veltsista, Paraskevi Danai (1) von Kries, Jens Peter Dr. (2) Walther, Wolfgang Prof. Dr. (145) Wenzel, Katrin Dr. (1) Willimsky, Gerald Dr. (1) Willnow, Thomas Prof. Dr. (1) Wolf, Jana Prof. Dr. (1) Zimmermann, Karin Dr. (1) (-) Smith, Janice (16) 2006 (1) 2008 (1) 2009 (2) 2011 (1) 2012 (1) 2013 (1) 2014 (1) 2016 (1) 2017 (2) 2020 (1) 2021 (1) 2022 (1) 2023 (2) Advanced Light Microscopy (1) AG Müller/Dechend (ECRC) (3) Anchored Signalling (106) Animal Phenotyping (4) Cardiac MRI (1) Clinical Research Unit (2) Computational Regulatory Genomics (2) Developmental Neurobiology (1) Genetics and Genomics of Cardiovascular Diseases (3) Genome Engineering & Disease Models (2) Genomics (2) Host-microbiome factors in cardiovascular disease (3) Hypertension-caused End-Organ Damage (3) Hypertension-Mediated End-Organ Damage (3) Integrative Vascular Biology (1) Intracellular Proteolysis (69) Molecular Biology of Peptide Hormones (5) Molecular Pathways in Cortical Development (1) Pancreatic Organoid Research and Disease Modeling (1) Pluripotent Stem Cells (2) Protein Production and Characterization (2) Proteome Dynamics (11) Proteomics (3) Proteomics and Metabolomics (1) Proteomics and Molecular Mechanisms of Neurodegenerative Diseases (2) RNA Biology and Posttranscriptional Regulation (2) Structural Biology of Membrane-Associated Processes (3) Transgenics (2) Translational Bioinformatics (1) Translational Cardiology and Functional Genomics (1) (-) Translational Oncology of Solid Tumors (16) 16 Results: Active Filter: Smith, JaniceTranslational Oncology of Solid Tumors Sort: Result score Newest to oldest Oldest to newest December 08, 2023 / Front Oncol GIPC1 regulates MACC1-driven metastasis F. Siegel H. Schmidt M. Juneja J. Smith P. Herrmann D. Kobelt K. Sharma I. Fichtner W. Walther G. Dittmar R. Volkmer F.G. Rathjen P.M. Schlag U. Stein January 07, 2023 / Int J Mol Sci Cantharidin and its analogue norcantharidin inhibit metastasis-inducing genes S100A4 and MACC1 P.C. Schöpe V. Zinnow M.A. Ishfaq J. Smith P. Herrmann R.H. Shoemaker W. Walther U. Stein November 12, 2022 / Nutrients MACC1-dependent antitumor effect of curcumin in colorectal cancer N. Güllü J. Smith P. Herrmann U. Stein August 26, 2021 / Oncogene The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis D. Kobelt D. Perez-Hernandez C. Fleuter M. Dahlmann F. Zincke J. Smith R. Migotti O. Popp S. Burock W. Walther G. Dittmar P. Mertins U. Stein August 03, 2020 / Cells Saffron crudes and compounds restrict MACC1-dependent cell proliferation and migration of colorectal cancer cells N. Güllü D. Kobelt H. Brim S. Rahman L. Timm J. Smith A. Soleimani S. Di Marco S. Bisti H. Ashktorab U. Stein August 01, 2017 / Ann Oncol Prognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studies U.P. Rohr P. Herrmann K. Ilm H. Zhang S. Lohmann A. Reiser A. Muranyi J. Smith S. Burock M. Osterland K. Leith S. Singh P. Brunhoeber R. Bowermaster J. Tie M. Christie H.L. Wong P. Waring K. Shanmugam P. Gibbs U. Stein June 01, 2017 / PLoS Biol Statin and rottlerin small-molecule inhibitors restrict colon cancer progression and metastasis via MACC1 M. Juneja D. Kobelt W. Walther C. Voss J. Smith E. Specker M. Neuenschwander B.O. Gohlke M. Dahlmann S. Radetzki R. Preissner J.P. von Kries P.M. Schlag U. Stein November 17, 2016 / Oncogene SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival F. Schmid Q. Wang M.R. Huska M.A. Andrade-Navarro M. Lemm I. Fichtner M. Dahlmann D. Kobelt W. Walther J. Smith P.M. Schlag U. Stein May 30, 2014 / Oncotarget RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis M. Dahlmann A. Okhrimenko P. Marcinkowski M. Osterland P. Herrmann J. Smith C.W. Heizmann P.M. Schlag U. Stein December 01, 2013 / Neuro Oncol Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis C. Hagemann S. Fuchs C.M. Monoranu P. Herrmann J. Smith T. Hohmann U. Grabiec A.F. Kessler F. Dehghani M. Loehr R.I. Ernestus G.H. Vince U. Stein Pagination Current page 1 Page 2 Next page Next › Last page Last »
December 08, 2023 / Front Oncol GIPC1 regulates MACC1-driven metastasis F. Siegel H. Schmidt M. Juneja J. Smith P. Herrmann D. Kobelt K. Sharma I. Fichtner W. Walther G. Dittmar R. Volkmer F.G. Rathjen P.M. Schlag U. Stein
January 07, 2023 / Int J Mol Sci Cantharidin and its analogue norcantharidin inhibit metastasis-inducing genes S100A4 and MACC1 P.C. Schöpe V. Zinnow M.A. Ishfaq J. Smith P. Herrmann R.H. Shoemaker W. Walther U. Stein
November 12, 2022 / Nutrients MACC1-dependent antitumor effect of curcumin in colorectal cancer N. Güllü J. Smith P. Herrmann U. Stein
August 26, 2021 / Oncogene The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis D. Kobelt D. Perez-Hernandez C. Fleuter M. Dahlmann F. Zincke J. Smith R. Migotti O. Popp S. Burock W. Walther G. Dittmar P. Mertins U. Stein
August 03, 2020 / Cells Saffron crudes and compounds restrict MACC1-dependent cell proliferation and migration of colorectal cancer cells N. Güllü D. Kobelt H. Brim S. Rahman L. Timm J. Smith A. Soleimani S. Di Marco S. Bisti H. Ashktorab U. Stein
August 01, 2017 / Ann Oncol Prognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studies U.P. Rohr P. Herrmann K. Ilm H. Zhang S. Lohmann A. Reiser A. Muranyi J. Smith S. Burock M. Osterland K. Leith S. Singh P. Brunhoeber R. Bowermaster J. Tie M. Christie H.L. Wong P. Waring K. Shanmugam P. Gibbs U. Stein
June 01, 2017 / PLoS Biol Statin and rottlerin small-molecule inhibitors restrict colon cancer progression and metastasis via MACC1 M. Juneja D. Kobelt W. Walther C. Voss J. Smith E. Specker M. Neuenschwander B.O. Gohlke M. Dahlmann S. Radetzki R. Preissner J.P. von Kries P.M. Schlag U. Stein
November 17, 2016 / Oncogene SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival F. Schmid Q. Wang M.R. Huska M.A. Andrade-Navarro M. Lemm I. Fichtner M. Dahlmann D. Kobelt W. Walther J. Smith P.M. Schlag U. Stein
May 30, 2014 / Oncotarget RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis M. Dahlmann A. Okhrimenko P. Marcinkowski M. Osterland P. Herrmann J. Smith C.W. Heizmann P.M. Schlag U. Stein
December 01, 2013 / Neuro Oncol Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis C. Hagemann S. Fuchs C.M. Monoranu P. Herrmann J. Smith T. Hohmann U. Grabiec A.F. Kessler F. Dehghani M. Loehr R.I. Ernestus G.H. Vince U. Stein